Recruiting Type 1 Diabetes Studies in Kansas City
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insu...
About Type 1 Diabetes Clinical Trials in Kansas City
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.
There are currently 2 type 1 diabetes clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 256 participants. Research is being sponsored by Zucara Therapeutics Inc., Emily K. Sims. Clinical trial participation is free and participants receive study-related medical care at no cost.
Type 1 Diabetes Clinical Trials in Kansas City — FAQ
Are there type 1 diabetes clinical trials in Kansas City?
Yes, there are 2 type 1 diabetes clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kansas City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.
Are clinical trials in Kansas City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.
What type 1 diabetes treatments are being tested?
The 2 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.
Data updated March 2, 2026 from ClinicalTrials.gov